StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Sandler on Boston Scientific (BSX): 'The current pullback an attractive entry point'
May 19, 2026 9:56 AM
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $90.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
